4.7 Article

Predictors of serum 25-hydroxyvitamin D concentrations among postmenopausal women: the Women's Health Initiative Calcium plus Vitamin D Clinical Trial

期刊

AMERICAN JOURNAL OF CLINICAL NUTRITION
卷 91, 期 5, 页码 1324-1335

出版社

OXFORD UNIV PRESS
DOI: 10.3945/ajcn.2009.28908

关键词

-

资金

  1. New York State Department of Health
  2. New York State Breast Cancer Research and Education Fund [C020920]
  3. National Heart, Lung, and Blood Institute
  4. National Institutes of Health
  5. US Department of Health and Human Services [N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, 44221]

向作者/读者索取更多资源

Background: It is unclear how well surrogate markers for vitamin D exposure (eg, oral intake of vitamin D and estimates of sunlight exposure), with and without consideration of other potential predictors of 25-hydroxyvitamin D [25(OH) D] concentrations, similarly rank individuals with respect to 25(OH) D blood concentrations. Objective: The objective was to determine how much variation in serum 25(OH) D concentrations (nmol/L) could be explained by a predictive model with the use of different vitamin D surrogate markers (latitude of residence, mean annual regional solar irradiance estimates, and oral sources) and other individual characteristics that might influence vitamin D status. Design: A random sample of 3055 postmenopausal women (aged 50-70 y) participating in 3 nested case-control studies of the Women's Health Initiative Calcium plus Vitamin D Clinical Trial was used. Serum 25(OH) D values, assessed at year 1 (1995-2000), and potential predictors of 25(OH) D concentrations, assessed at year 1 or Women's Health Initiative baseline (1993-1998), were used. Results: More than half of the women (57.1%) had deficient (, 50 nmol/L) concentrations of 25(OH) D. Distributions of 25(OH) D concentrations by level of latitude of residence, mean annual regional solar irradiance, and intake of vitamin D varied considerably. The predictive model for 25(OH) D explained 21% of the variation in 25(OH) D concentrations. After adjustment for month of blood draw, breast cancer status, colorectal cancer status, fracture status, participation in the hormone therapy trial, and randomization to the dietary modification trial, the predictive model included total vitamin D intake from foods and supplements, waist circumference, recreational physical activity, race-ethnicity, regional solar irradiance, and age. Conclusions: Surrogate markers for 25(OH) D concentrations, although somewhat correlated, do not adequately reflect serum vitamin D measures. These markers and predictive models of blood 25(OH) D concentrations should not be given as much weight in epidemiologic studies of cancer risk. Am J Clin Nutr 2010;91:1324-35.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据